Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2

MLA

Andrew J. Tebben, et al. “Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2.” ACS Medicinal Chemistry Letters, vol. 12, May 2021, pp. 969–75. EBSCOhost, https://doi.org/10.1021/acsmedchemlett.1c00082.

APA

Andrew J. Tebben, Sandhya Mandlekar, Michael A. Gallela, Songmei Xu, Robert J. Cherney, Mary Ellen Cvijic, Anne Rose, John V. Duncia, Mary F. Malley, Yang Michael G, Arvind Mathur, Percy H. Carter, Amy A. Sarjeant, Jian Pang, Bei Wang, Zili Xiao, Ragini Vuppugalla, Purnima Khandelwal, Qihong Zhao, … Rulin Zhao. (2021). Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2. ACS Medicinal Chemistry Letters, 12, 969–975. https://doi.org/10.1021/acsmedchemlett.1c00082

Chicago

Andrew J. Tebben, Sandhya Mandlekar, Michael A. Gallela, Songmei Xu, Robert J. Cherney, Mary Ellen Cvijic, Anne Rose, et al. 2021. “Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2.” ACS Medicinal Chemistry Letters 12 (May): 969–75. doi:10.1021/acsmedchemlett.1c00082.